Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
ADMA Biologics Inc - Common Stock
(NQ:
ADMA
)
8.770
+0.050 (+0.57%)
Streaming Delayed Price
Updated: 3:53 PM EDT, Jun 26, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about ADMA Biologics Inc - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
Next >
3 Biotech Firms With Major Potential Catalysts in the Coming Months
↗
June 21, 2026
The pharmaceutical industry is known for big risks and big rewards among investors; those willing to take on the risk may want to watch these firms.
Via
MarketBeat
Topics
Intellectual Property
Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline
↗
May 21, 2026
Bright Minds Biosciences develops serotonin-based therapeutics for neurological and neuropsychiatric conditions in a pre-clinical model.
Via
The Motley Fool
Topics
Intellectual Property
Regulatory Compliance
Why This Fund Added $12 Million to a Biotech Stock That's Now Down 58% in a Year
↗
May 21, 2026
ADMA Biologics develops plasma-derived therapies for immune deficiencies and infectious diseases, leveraging a vertically integrated model.
Via
The Motley Fool
Topics
Economy
Regulatory Compliance
ADMA Biologics (NASDAQ:ADMA) Shares Plunge on Q1 Miss and Revenue Guidance Cut
↗
May 06, 2026
Via
Chartmill
ADMA Biologics Inc (NASDAQ:ADMA) Reports Record 2025 Results Driven by ASCENIV, Provides 2026 Outlook
↗
February 25, 2026
Via
Chartmill
Earnings Scheduled For November 5, 2025
↗
November 05, 2025
Via
Benzinga
Earnings Scheduled For August 6, 2025
↗
August 06, 2025
Via
Benzinga
ADMA (ADMA) Q1 2026 Earnings Transcript
↗
May 06, 2026
ADMA (ADMA) Q1 2026 Earnings Transcript
Via
The Motley Fool
What's going on in today's after hours session
↗
May 06, 2026
Via
Chartmill
The Great Rotation of 2026: Why Small Caps are Finally Dethroning the Tech Giants
March 27, 2026
The financial landscape of 2026 has been defined by a seismic shift in capital allocation that few analysts predicted with such intensity. For the first time in over a decade, the long-dormant Russell...
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Is ADMA Biologics Gaining or Losing Market Support?
↗
August 01, 2025
Via
Benzinga
Is ADMA Biologics Gaining or Losing Market Support?
↗
July 02, 2025
Via
Benzinga
What's going on in today's pre-market session
↗
March 27, 2026
Via
Chartmill
Why Are Shares Of ADMA Biologics Falling Today?
↗
March 26, 2026
ADMA Biologics, Inc. (NASDAQ: ADMA) shares are tumbling on Thursday as traders lean into risk-off positioning and punish weaker charts in a down tape. The Nasdaq is down 0.91% while the S&P 500 has...
Via
Benzinga
Topics
Stocks
Structure Therapeutics Slides 28% This Year as $6 Million Stake Emerges
↗
March 22, 2026
Structure Therapeutics advances oral therapies for diabetes, obesity, and pulmonary disease through its clinical-stage drug pipeline.
Via
The Motley Fool
ADMA Biologics (ADMA) Q4 2025 Earnings Transcript
↗
February 28, 2026
ADMA Biologics (ADMA) Q4 2025 Earnings Transcript
Via
The Motley Fool
Chime Is Down 27% From Its IPO Price, Yet Posting 29% Revenue Growth: Why This New $15 Million Bet Stands Out
↗
February 14, 2026
This digital banking platform targets U.S. mass market consumers with mobile-first, fee-free services and strategic bank partnerships.
Via
The Motley Fool
Topics
Initial Public Offering
Regulatory Compliance
Solaris Stock Is Up 100% This Past Year, and One Fund Is Betting $29 Million on More Growth
↗
February 14, 2026
Solaris Energy Infrastructure delivers automation and logistics solutions to U.S. oil and gas operators using proprietary technologies.
Via
The Motley Fool
Topics
Energy
Stock Up 40% in a Year, $706 Million in Quarterly Sales: Why Boot Barn’s Trimmed Stake Deserves a Look
↗
February 14, 2026
Boot Barn Holdings operates over 500 stores nationwide, supplying western and workwear apparel to a diverse U.S. customer base.
Via
The Motley Fool
Topics
Regulatory Compliance
This Biotech Is Up 194% in a Year but One Investor Took Millions Off the Table
↗
December 28, 2025
When a biotech rallies nearly 200% and still gets trimmed, the real story likely isn’t about fear or a loss of conviction.
Via
The Motley Fool
Topics
Regulatory Compliance
ANI Stock Is Up 49% This Past Year, Revenue Is Surging, and One Fund Still Walked Away
↗
December 28, 2025
ANI is firing on all cylinders operationally, which makes this exit less about fundamentals and more about portfolio discipline at a moment when expectations might be sky-high.
Via
The Motley Fool
Topics
Regulatory Compliance
ADMA Biologics Inc (NASDAQ:ADMA) Emerges as a Top GARP Investment Candidate
↗
December 05, 2025
ADMA Biologics exemplifies GARP investing with strong revenue & earnings growth, high profitability, and a reasonable valuation relative to its biotech peers.
Via
Chartmill
This Small-Cap Fund Just Dumped $7 Million in ADMA Stock — Here’s Why
↗
November 01, 2025
This Small-Cap Fund Just Dumped $7 Million in ADMA Stock — Here’s Why
Via
The Motley Fool
Redwire Posts Downbeat Q2 Results, Joins Tandem Diabetes Care, Fortinet, Symbotic And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
↗
August 07, 2025
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
August 07, 2025
Via
Benzinga
Why Groupon Shares Are Trading Higher By Around 28%; Here Are 20 Stocks Moving Premarket
↗
August 07, 2025
Via
Benzinga
Adma Biologics (ADMA) Q2 Revenue Up 14%
↗
August 06, 2025
Via
The Motley Fool
Topics
Economy
ADMA BIOLOGICS INC (NASDAQ:ADMA) - A Strong Growth Candidate Meeting Minervini's Criteria
↗
June 13, 2025
ADMA Biologics (NASDAQ:ADMA) meets Minervini’s Trend Template with strong technicals and high-growth fundamentals, making it a candidate for momentum investors.
Via
Chartmill
ADMA BIOLOGICS INC (NASDAQ:ADMA) – A Strong Growth Stock with Technical Breakout Potential
↗
June 09, 2025
ADMA Biologics (NASDAQ:ADMA) shows strong growth fundamentals and a technical breakout setup, making it a stock to watch in the biotech sector.
Via
Chartmill
ADMA BIOLOGICS INC (NASDAQ:ADMA) – A High Growth Momentum Stock with Strong Technical Setup
↗
June 07, 2025
ADMA Biologics (NASDAQ:ADMA) shows strong earnings momentum and a favorable technical setup, making it a candidate for high-growth investors. The stock has outperformed peers and may present a breakout...
Via
Chartmill
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
